Clinical trials for atrial fibrillation treatments often lack diverse patient populations, according to a recently published research letter in JACC: Clinical Electrophysiology. It was the top story in cardiology last week.

Another top story was about the risk for CVD in people who adhere to healthy eating patterns.

Read these and top stories in cardiology below:

Diverse populations underrepresented in AF clinical trials

African American and Hispanic populations were often underrepresented in clinical trials of treatments for atrial fibrillation, according to a research letter published in JACC: Clinical Electrophysiology. Read more.

Consistent healthy eating reduces CVD risk

People with greater adherence to healthy eating patterns had a lower risk for CVD, according to a study published in JAMA Internal Medicine. Read more.

Infective endocarditis confers poor outcomes after TAVR

Among patients who had transcatheter aortic valve replacement, infective endocarditis was linked to elevated risk for mortality and stroke, researchers reported. Read more.

Heart transplantation improves survival regardless of LVAD therapy

Patients who underwent heart transplant with or without bridge to transplant left ventricular assist device therapy had superior 5-year survival vs. those with LVAD destination therapy when matched on several clinical factors, a study found. Read more.

Degree of myocardial injury severity may affect survival in COVID-19

The prevalence of myocardial injury in acute COVID-19 is approximately 36%, but its presence was significantly associated with worse outcomes, researchers reported. Read more.